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A major problem using tumour-specific agents such as mono-
clonal antibodies recognizing tumour-associated antigens and DNA
vectors for gene therapy, is the low tumour uptake of the therapeutic
agents. The elevated interstitial fluid pressure (IFP) (Jain and
Baxter, 1988; Boucher et al, 1990) hinders convection across the
capillary wall and through the interstitium. Extravasation of
therapeutic agents requires a net transvascular pressure gradient,
according to the Starling equation (Kedem and Katchalsky, 1958).
However, due to the high permeability of microvessels and lack of
functional lymphatics in tumours, the microvascular pressure and
the IFP are almost equal (Boucher and Jain, 1992), resulting in a
low transvascular pressure gradient. 
Macromolecules able to extravasate have to penetrate the
interstitium by diffusion and convection (Jain, 2001). The inter-
stitium consists of a protein network embedded in a hydrophilic
gel of glycosaminoglycans (GAG) and proteoglycans. It is not
clear whether the network of fibrillar collagen or the GAG gel
plays the most important role in limiting the interstitial transport
of macromolecules. The collagen network which represents the
large-scale structure and the structural element of the intersti-
tium, has been assumed to play a minor role for transport, where-
as the stabilizing hydrophilic GAG gel has been thought to
determine the pore size and thereby regulate the interstitial
movement of fluid and macromolecules in tumour tissue (Swabb
et al, 1974; Jain, 1987). However, recently the diffusion coeffi-
cient and hydraulic conductivity in tumour interstitium were
found to correlate with collagen rather than with GAG content
(Netti et al, 2000). 
The production of extracellular matrix (ECM) macromolecules
in the interstitium is a result of an active interaction between the
tumour cells and the stromal cells of the host (Gullino and
Grantham, 1962; Knudson et al, 1984). The fibroblasts synthesize
the ECM constituents in most tumours, whereas the tumour cells
regulate the production either directly or indirectly by releasing
cytokines that modify the phenotypic expression of the mesen-
chymal cells of the host (Iozzo, 1985). The composition and struc-
ture of ECM as well as parameters such as IFP, vascular structure
and vascular permeability are influenced by the microenvironment
(Sunderkötter et al, 1994; Fidler, 1995; Fukumura et al, 1998), and
thus depending on the site of tumour growth (Fukumura et al,
1997; Hobbs et al, 1998; Brekken et al, 2000a). 
Based on all this, we proposed that the tumour uptake of anti-
bodies (IgG) is hindered both by the high IFP and by the ECM
composition, and that these parameters are depending on the site
of tumour growth. To test this hypothesis, tumour uptake of 
fluorochrome-labelled IgG was correlated with IFP and the content
of ECM constituents in human osteosarcoma xenografts growing
either ectopically (subcutaneously) or orthotopically (around femur)
in athymic mice. The influence of the microenvironment on the
vasculature was assessed by stereological characterization of vas-
cular structure parameters in the ectopic and orthotopic tumour
models.
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MATERIALS AND METHODS 
Tumours 
Xenografts were grown in female BALB/c nu/nu mice (Möllergård
Breeding Center, Copenhagen, Denmark) in 2 different microenvi-
ronments. The orthotopic (o.t.) tumours were initiated by injecting
2 ×  106 human osteosarcoma cells from the cell line OHS (Fodstad
et al, 1986) adjacent to the periosteum of both femurs, allowing
the tumour to grow around and infiltrate the bones. The subcuta-
neous (s.c.) tumours were initiated by implanting tumour chunks
(~1 mm3) from subcutaneously growing OHS xenografts subcuta-
neously on both hind legs. The growth curve and histology of the 2
tumour models have been reported previously (Brekken et al,
2000a). Tumour dimensions were measured with a steel calliper.
For subcutaneous tumours, the tumour width and length were
measured, whereas for orthotopic tumour the 2 widths (width a
and width b) of the leg of mouse without tumour and of leg with
surrounding tumour were measured. Volumes were estimated using
the formula for the volume of a prolate ellipsoid (subcutaneous: V =
π /6 × (width)2 × length, orthotopic: V = π /6 × (width a)2 × (width b)).
The volume of orthotopic tumours were estimated by subtracting
the leg volume of mouse without tumour from the volume of leg
with surrounding tumour. The animals were kept under pathogen-
free conditions and were allowed food and water ad libitum. 
Experimental procedure 
3–5 weeks after tumour implantation, the mice were anasthesized
using Hypnorm/Dormicum/sterile water, 1:1:2; 1 ml kg–1 body-
weight, and the IFP measured using the wick-in-needle method.
Fluoresecin-5-isothiocyanate (FITC)-labelled IgG, 20 mg ml–1 in
200 µ l, was injected in the tail vein immediately after IFP had
been measured. The FITC-IgG was allowed to accumulate in the
tumour for 24 h. The mice were then sacrificed by cervical dislo-
cation and the tumours cut in 2 parts. Subcutaneous tumours were
cut through the centre, and orthotopic tumours along the perios-
teum. One part was placed in liquid N2 for measurements of IgG
uptake. In case of the larger tumours (volume > 400 mm3), the
second part was divided between measurements of ECM consti-
tuents and estimation of the vasculature, and placed in liquid N2 or
fixed in 4% buffered formaldehyde, respectively. In smaller tum-
ours only IFP and ECM constituents were measured. 
Tumour uptake of IgG 
The uptake of FITC-labelled IgG was measured using confocal
laser scanning microscopy. IgG (rabbit γ -globulin, Sigma, St Louis,
MO) was labelled with FITC (Molecular Probes, Eugene, OR) by
incubating 2 mg ml–1 FITC in DMSO (Sigma, St Louis, MO) per
mg IgG for 4 h at room temperature. Bound IgG-FITC was sepa-
rated from unbound FITC using a PD-10 sepharex G25M column
(Amersham Pharmacia Biotech, Buckinghamshire, UK). The ratio
between number of FITC molecules per molecule of IgG was
approximately 7. 
Frozen sections of the tumours, 5 µ m thick, were analysed using
a 600 MRC (BioRad, Hercules, CA) epi confocal laser scanning
microscope (Nikon, Japan). The sections were mounted using
Vectashield (Vector Laboratories, Burlingame, CA) to reduced
bleaching of the fluorophore. As no other handling of the sections
was done, the loss of IgG was assumed to be minimal. The 488 nm
argon-laser line was used to excite FITC, and the fluorescence
above 520 nm detected. To ensure equally illumination and bleach-
ing of the sections, all sections were only scanned once prior
to recording an image, and fluorescent calibration particles
(Polysciences, Warrington, PA) were used to control for day-to-day
variations in fluorescence intensity. 
The fluorescence intensity was quantified by measuring the
average pixel intensity (sum of all pixel values per number of
pixels) in 4–6 fields across the section, using a 10   objective. The
fluorescence intensity profile from one periphery to the other was
thus recorded. Fluorescence intensities of necrotic areas were not
measured as IgG often was trapped in such areas. 10 sections
approximately 100 µ m apart were measured per tumour. IgG
uptake was expressed as percentage increase of fluorescence inten-
sity relative to autofluorescence of the tissue. 
Interstitial fluid pressure measurements 
IFP was measured using the wick-in-needle technique described in
detail elsewhere (Fadnes et al, 1977). Briefly, 4 nylon sutures
(6–0 Ethilon; Ethicon Inc, Sommerville, NJ) were placed within a
standard 23 gauge hypodermic needle with a side hole 4 mm
from the tip. The needle was connected to a pressure transducer
(SensoNor, Horten, Norway) via polyethylene tubing (PE-
50, Becton-Dickinson, Sparks, MD) filled with sterile heparinized
phosphate-buffered saline (PBS) (70 units ml–1). Pressures were
monitored online using a MacLab analogue to digital data recording
system with a sampling rate of 4 Hz (MacLab4/e, ADInstruments,
Hastings, UK). Fluid communication between the transducer and
the tumour tissue was tested by compression and decompression of
the polyethylene tubing, and accepted when the IFP did not differ
more than 20% after compression and decompression. 
Disintegration of tissue 
The tumour tissue had to be solubilized in order to measure
ECM constituents. The excised tumour was cut in pieces and
placed in digest buffer (50 mg tissue ml–1). The buffer consisted of
125 µ g ml–1 papain (Sigma, St Louis, MO) in 0.1 M Na-phosphate
(Merck, Darmstadt, Germany), 5 mM Na2EDTA (Merck,
Darmstadt, Germany), and 5 mM cysteine-HCl (Sigma, St Louis,
MO), pH 6.0. The tumour tissue was finely dispersed with a
homogenizer (Polytron; Brinkmann Instrument, Westbury, NY),
and incubated in the digest buffer for 18 h at 60˚C. 
GAG content 
The total amount of GAG was determined by the reaction of
uronic acid with carbazole as described by Bitter and Muir (1962).
Briefly, 0.5 ml solubilized tissue diluted (1:3) in water saturated
with benzoic acid was carefully layered onto 3 ml of sulfuric acid
at 0˚C, shaken, and boiled for 10 min. After cooling to room
temperature, 100 µ l carbazole (Sigma, St Louis, MO) reagent was
added, the samples shaken, boiled for 15 min and cooled to room
temperature. The absorbance at 530 nm was measured using a
spectrophotometer (model UV-1201; Shimadzu, Kyoto, Japan),
and the content of GAG equivalent to uronic acid (UA) was deter-
mined from the UA standard curve. 
Sulfated GAG (s-GAG) was measured using the Blyscan
proteoglycan and s-GAG assay (Biocolor Ltd, Belfast, Ireland),1970 C de Lange Davies et al
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which is based on the specific binding of the cationic dye
1,9 dimethylmethylene blue (Farndale et al, 1986). Briefly, 100 µ l
of diluted (1:4) solubilized sample and 1 ml Blyscan dye reagent
was mixed for 30 min at room temperature and centrifuged for
10 min. The precipitated polysaccharide-dye complex was
dissolved in 1 ml dissociation reagent. The absorbance of bound
dye was measured at 656 nm. The s-GAG equivalent to UA was
found by measuring the standards of the Blyscan assay with the
assay for total GAG. 
The content of hyaluronic acid (HA) was estimated as the dif-
ference between total GAG and s-GAG, both expressed equivalent
to UA. 
Collagen content 
The amount of collagen was determined by measuring hydroxy-
proline according to Woessner (1961). Briefly, 100 µ l of solubilized
sample was hydrolysed by adding HCl to a final concentration of
6 N. The samples were hydrolysed at 110˚C for 18 h, followed by
neutralization using 2.5 N NaOH. Hydroxyproline was oxidated by
adding 1 ml chloroamine T (Sigma, St Louis, MO) per 2 ml sample,
mixed and left at room temperature for 20 min. Cloroamine T was
destroyed by adding 1 ml 3.15 M percloric acid (Merck, Darmstadt,
Germany) mixed and left at room temperature for 5 min. Finally,
1 ml p-dimethylaminobenzaldehyde (Sigma, St Louis, MO) was
added, mixed and placed at 60˚C for 20 min. The absorbance was
measured spectrophotometrically at 557 nm. The concentration of
hydroxyproline was determined from the hydroxyproline standard
curve, and the content of collagen estimated by assuming 6.94 µ g
collagen µ g–1 hydroxyproline (Jackson and Cleary, 1976). 
Vascular structure 
Formalin-fixed and paraffin-embedded tumours were cut into 5 µ m
sections. The paraffin was removed by xylene, and the sections
rehydrated and trypsin treated (0.1%) (Type II-S, Sigma, St Louis,
MO) for 45 min at 37˚C, before blocking against endogenous
peroxidase using 3% H2O2 (Merck, Darmstadt, Germany). The
endothelial cells were visualized by staining against CD 31 using
the tyramide signal amplification kit (NEN Life Science Products,
Boston, MA). Tumour sections were incubated in a humidity
chamber overnight at 4˚C with anti-mouse CD31 monoclonal anti-
body (clone MEC13.3; PharMingingen, San Diego, CA) diluted
1:30, followed by incubation at room temperature for 30 min
with biotinylated anti-rat IgG (Vector Lab, Burlinghame, CA)
and peroxidase-conjugated streptavidin (NEN Life Science Products,
Boston, MA). The amplification procedure included incubation
with biotinyl tyramide for 10 min and an additional strepta-
vidin–peroxidase incubation before applying the diaminobenzidine
substrate (Sigma, St Louis, MO). The sections were counterstained
with haematoxylin (Sigma, St Louis, MO), dehydrated and
mounted using Corbit-balsam (Hecht, Germany). 
Quantitative information on microvascular structure was
obtained using stereological morphometry (Gundersen, 1979;
Weibel, 1979). For this purpose, a quadratic counting grid was
used. Sections of tumour tissue were examined in a Zeiss light
microscope, equipped with a drawing attachment, thus allowing
the grid to be visually merged with the image of the tissue. Based
on counting performed in the microscope, the microvascular
volume, surface and length per unit volume of tumour tissue
were determined. 8 sections approximately 100 µ m apart, were
examined from each tumour, and in each section systematic fields
were observed by moving the object stage of the microscope, in 1
mm steps. The stereological parameters were estimated for each
tumour by summing the counts over all fields in the section
according to the following formulae:
n is the number of fields examined in the section. The values for
each tumour are the average of 8 sections. PKS is the number of test
points hitting the wall or the lumen of a microvessel in any given
field, and PTS is the total number of test points hitting any part of
the section. IS is the number of intersections between the test lines
and the wall of a microvessel in any given field, and LTS is the total
test-line length within the section. NKS is the number of
microvessel transections recognized within the grid boundaries in
any given field, and AS is the test area, i.e. the part of the grid area
falling within the section. In determining whether or not to count a
given vascular profile, the criteria described by Gundersen (1979)
were applied. 
The stereological formulae are derived based on the assumption
that the section thickness is negligible compared with the dimen-
sions of the features of interest, and that the sections constitute a
true random sample of the tissue structure. These criteria are
considered fulfilled to an acceptable degree as the tissue samples
were embedded without any consideration given to their position
or orientation in the blocks. 
Statistical analysis 
Statistical comparisons of Gaussian data were performed using the
one-way analysis of variance, ANOVA. The significance criterion
of P < 0.05 was used. Correlation analyses were performed by
linear regression. 
RESULTS 
Uptake of IgG versus tumour volume and IFP 
The uptake of IgG in orthotopic tumours correlated inversely
with the tumour volume and with IFP, whereas no such correlation
was seen for subcutaneously growing tumours (Figure 1 A, B).
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Correspondingly, the orthotopic tumours showed a positive correla-
tion between tumour volume and IFP. No such correlation was seen
for subcutaneously growing tumours (Figure 1C). The correlation
between tumour volume and IFP is in accordance with our previous
findings (Brekken et al, 2000a). 
Comparing the average IgG uptake and IFP for all orthotopic or
subcutaneous tumours, the uptake of IgG was found to be indepen-
dent of the site of tumour growth, whereas orthotopic tumours had
about 50% higher IFP than the subcutaneous tumours (Figure 1D).
To compare the uptake of IgG between orthotopic and subcutaneous
tumours of similar size, the tumours were divided into 3 groups
according to their volume. The uptake of IgG was found to be signif-
icantly higher in small (< 400 mm3) orthotopic tumours compared
with corresponding subcutaneous tumours, whereas no difference
was seen for larger tumours (400–1000 mm3 or > 1000 mm3). 
Distribution of IgG in the tissue 
The distribution of IgG in the tumours was heterogeneous.
Brightest fluorescence intensity was seen around structures resem-
bling blood vessels. A typical example is shown in Figure 2. The
bright fluorescent areas stretched approximately 10–70 µ m from
the vessels, both in orthotopic (panel A, B) and subcutaneous
(panel C, D) tumours. In some subcutaneous tumours the fluores-
cence covered a larger area than seen in orthotopic tumours. The
fluorescence intensity was rather weak outside the bright fluores-
cent area with some scattered fluorescent spots. A higher fluores-
cence intensity and a higher number of fluorescent areas were seen
in the periphery (panel A and C) compared to the central part
(panel B and D) of some of the tumours (Figure 2). The majority
of the tumours, (70% of the orthotopic and 85% of the subcuta-
neous tumours), however, had weak fluorescence intensity
throughout the sections and no differences in fluorescence inten-
sity between the periphery and central parts of the tumours could
be detected. 
Content of ECM versus IgG uptake, tumour volume and
IFP 
To study the impact of the ECM composition on the uptake of
macromolecules, the content of collagen, total GAG, s-GAG, and
HA were measured in each tumour. No correlation between IgG
uptake and any of the ECM constituents was seen for either of the
2 tumour models (Figure 3). 
Regression analysis of the content of the ECM constituents
versus tumour volume (Figure 4) or IFP (data not shown) were
done. Collagen content decreased with increasing tumour volume
for orthotopic tumours, whereas a positive correlation was seen for
subcutaneous tumours. No correlation between total GAG content
and the tumour volume was found. However, s-GAG increased
with increasing volume of orthotopic tumours, and correspond-
ingly HA decreased. No correlation between IFP and any of the
ECM constituents was seen. 
Content of ECM and the site of tumour growth 
Comparing the average content of ECM constituents in orthotopi-
cally and subcutaneously growing tumours, significant differences
were found (Figure 5). Orthotopic tumours had a significantly
lower level of total GAG, a higher level of s-GAG and a
correspondingly lower level of HA compared with subcutaneous
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tumours (Figure 5A). The collagen content was significantly
higher in orthotopic tumours (Figure 5B). The ECM constituents
in the periphery and central parts of the tumour were compared.
Only s-GAG showed a significantly higher level in central parts of
orthotopically growing tumours. Collagen, total GAG or HA
showed no such variations (data not shown). 
The content of the ECM constituents was found to be lower in
tumour tissue compared with normal tissue (Table 1). Collagen and
A B
C D
20 µ M
Figure 2 Distribution of IgG-FITC in the periphery (A,C) and central part (B,D) of orthotopic (A,B) and subcutaneous (C,D) xenografts. Bar = 20 µ m 
Table 1 Content of collagen, total GAG, s-GAG and HA in normal and tumour tisssue1
Tissue Collagen Tot GAG s-GAG HA
( g/mg) ( g UA eqv/mg) ( g UA eqv/mg) ( g UA eqv/mg)
Skin 27.33 ± 8.06 6.90 ± 0.36 1.09 ± 0.09 5.82 ± 0.39
Muscle 2.84 ± 0.17 2.33 ± 0.16 0.38 ± 0.02 1.95 ± 0.16
Sc ostosarcoma 1.57 ± 0.11 1.19 ± 0.03 0.44 ± 0.02 0.71 ± 0.04
Ot osteosarcom 2.04 ± 0.18 1.04 ± 0.03 0.71 ± 0.02 0.34 ± 0.04
1GAG, s-GAG and HA was measured equivalent to UA per mg wet tissueIgG-uptake, interstitial fluid pressure and stroma 1973
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total GAG were approximately 15- and 6-fold lower in tumours than
in skin. The difference between muscle and tumours was smaller. 
Uptake of IgG and vascularization 
To study the influence of the microenvironment on the vascular
structure, vascular volume, surface and length were estimated by
stereological analysis. Subcutaneous tumours were less vascular-
ized than orthotopic tumours, demonstrated by approximately 2-
and 3-fold lower vascular surface and vascular length densities
(Figure 6). The vascular volume seemed to be smaller in subcuta-
neous tumours than orthotopic, but the difference was not signifi-
cant. Regression analysis of IgG uptake and the 3 vascular
parameters did not show any correlation (data not shown). 
DISCUSSION 
Correlation between uptake of IgG and IFP depends on
the site of tumour growth 
The high IFP seems to be the most dominant factor in
limiting the uptake of macromolecules in orthotopically growing
osteosarcoma xenografts. Tumour uptake of IgG correlated
inversely with IFP, and with the volume of orthotopic tumours,
but not with the ECM constituents. The increased IgG uptake in
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small orthotopic tumour is probably caused by an increased trans-
vascular flux, thus the low IFP in small orthotopic tumours indi-
cates increased transvascular flux. The enhanced IFP is driven by
the microvascular pressure, and the hydrostatic pressure gradient
across the vascular wall in tumours is normally very low
(Boucher and Jain, 1992). However, in the periphery of the tum-
our, IFP decreases and the transvascular flux is higher than in the
central parts of the tumour (Jain and Baxter, 1988). Therefore, the
increased uptake of IgG might take place in the periphery of the
tumour. This is consistent with the images of the distribution of
IgG in small tumours (Figure 2) which showed a higher uptake
of IgG in the periphery than in the central parts of the tumour.
Fluorescent IgG was observed around structures resembling
vessels indicating that IgG was able to penetrate approximately
10–70 µ m into the interstitium. The high IFP might impede
further penetration. Enhanced macromolecule uptake in tumour
tissue has been demonstrated by periodic cycling the IFP using
hyaluronidase (Brekken et al, 2000b) or angiotensin II (Netti et al,
1999), thereby increasing the transvascular flux and uptake of
antibody. Also, lowering the IFP using prostaglandin E1 has been
shown to increase the transvascular transport and tumour uptake
of low-molecular-weight molecules (Rubin et al, 2000). 
The correlation between IgG uptake and IFP might reflect
changes in vessel permeability, as the high interstitial fluid pres-
sure is caused by the hyperpermeability of tumour vessels
(Boucher and Jain, 1992; Yuan, 1998). However, there is no clear
relationship between vascular permeability and tumour volume.
Reducing the tumour volume by anti-VEGF antibody reduces the
vascular permeability, as well as IFP (Lee et al, 2000). Thus, a
lower vascular permeability (but sufficient for IgG) associated
with a smaller tumour volume might induce a lower IFP and
thereby a higher uptake of macromolecules, as seen in the present
work. On the other hand, the volume of human melanomas are
reported to either show no correlation with vascular permeability,
or an inverse correlation (Bjørknæs and Rofstad, 2001). This is
consistent with the lack of correlation between IgG uptake, IFP
and volume of subcutaneous tumours. 
The correlation between macromolecule uptake and IFP
depended on the site of tumour growth. This is probably due to
differences in the microenvironment influencing parameters
important for macromolecule uptake. The vascular permeability is
reported to depend on the microenvironment (Fukumura et al,
1997). It is assumed that the balance of interactions between
cytokines released by host stromal cells and tumour cells deter-
mines the vascular permeability (Yuan, 1998). The growth curves
of the 2 tumour models were almost the same (Brekken et al,
2000a), indicating that the site-dependent correlation between IgG
uptake, IFP and tumour volume, was not due to differences in
growth rate. 
No correlation between uptake of IgG and content of
ECM 
Penetration of molecules through the interstitium is characterized
by the hydraulic conductivity and the diffusion coefficient. The
interstitial hydraulic conductivity is reported to correlate inversely
with GAG (Swabb et al, 1974), and in a mathematical model
found to affect the steepness of the IFP profile in the tumour
periphery (Jain and Baxter, 1988). However, within the range of
GAG measured in the OHS tumours (0.7–1.6 µ g UA equivalents
per mg tissue) no significant correlation between GAG (total
GAG, s-GAG, HA) and IFP or GAG and IgG uptake was seen. A
possible increase in hydraulic conductivity with decreasing GAG
might thus not be sufficient to increase the interstitial filtration of
fluid and extravasation of IgG. 
The high IFP might render convection impossible, thus diffu-
sion becomes the only transport mechanism. The diffusion coeffi-
cient is found to correlate inversely with the amount of collagen in
tumour tissue (Netti et al, 2000). The collagen content in the OHS
tumours varied a factor 10 (0.5–5 µ g mg–1 tissue), but even if the
diffusion coefficient increased with decreasing collagen content, it
did not have any major impact on the IgG uptake, probably due to
the low diffusion coefficient of such a large molecule. 
Diffusion and convection are probably not only depending on the
content of the ECM constituents, as the assembly and structure of
the ECM also play an important role (Pluen et al, 2001). Tumours
with a tight collagen network are more resistant to macromo-
lecular penetration than tumours with a loose collagen network.
Comparing the diffusion coefficient in tumours growing either in
dorsal chambers or in cranial windows, Pluen et al (2001) found a
lower diffusion coefficient in tumours in dorsal windows associ-
ated with a higher level of collagen organized into fibrils. The
collagen network stabilizes the GAG gel, and such stabilizing is
assumed to increase the hindrance of macromolecules through the
ECM (Netti et al, 2000). In accordance with this suggestion,
collagen gels in vitro are found to exhibit resistance to convection
which is significantly less than in tissue having the same content of
collagen (Jackson et al, 1991; Saltzman et al, 1994). Also gels
consisting of a combination of collagen and HA have a higher
resistance to macromolecular diffusion than gels of either collagen
or HA alone (Shenoy and Rosenblatt, 1995). Degradation of
collagen or the GAG gel will induce a structural change and remod-
elling of the ECM, affecting physiological properties of the tissue.
Collagenase is reported to increase the diffusion coefficient of IgG
in tumour tissue (Netti et al, 2000), whereas hyaluronidase reduces
the diffusion of albumin in lung interstitium (Qiu et al, 1999). 
ECM content depends on the site of tumour growth 
The content of collagen depended on the tumour volume, and the
correlation between collagen and tumour volume as well as the
average content of collagen depended on the site of tumour
growth. Collagen decreased or increased with the volume of ortho-
topically or subcutaneously growing tumours, respectively. This
difference might be due to organ-specific fibroblasts influencing
the production of collagen and collagenase as the tumours are
growing. Co-cultures of colon fibroblasts and colon carcinoma
cells are shown to produce collagenase IV, whereas skin fibro-
blasts and colon carcinoma cells did not (Fabra et al, 1992). A
higher density of host stromal cells has been found in tumours
with a high level of collagen organized into fibrils growing subcu-
taneously in dorsal chambers compared with the same tumours
grown in cranial windows where the collagen was less organized
(Pluen et al, 2001). 
The amount of total GAG was independent of the tumour
volume whereas HA and s-GAG depended on the volume of
orthotopically growing tumours. The amount of total GAG, HA
and s-GAG depended on the site of tumour growth. This might
indicate that either the fibroblasts or the interaction between the
osteosarcoma cells and the fibroblasts increased the synthesis of
GAG and HA in subcutaneously growing tumours. In accordance
with this, co-cultures of skin fibroblasts and lung carcinoma cells1976 C de Lange Davies et al
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have been shown to increase the synthesis of HA compared with
the 2 cell types alone, and contact between tumours cells and
fibroblasts appears to be required (Knudson et al, 1984). 
The amount of the ECM constituents was in the same range as
found in other human xenografts and murine tumours (Netti et al,
2000). Tumour tissue had lower level of collagen and GAG than
found in normal tissue, probably due to higher activity of degrada-
tion enzymes (Jain, 1987). 
Vascularization depends on the site of tumour growth 
The orthotopic tumours had a higher vascular density than the
subcutaneous tumours, demonstrated by a 2–3-fold increase in the
vascular surface and vascular length per tumour volume. The
difference probably reflects a lower number of vessels and an
increase in vascular diameter in subcutaneously growing tumours
compared with orthotopic tumours, and is consistent with the more
pronounced necrosis observed in the subcutaneous OHS tumours
compared to the orthotopic tumours (Brekken et al, 2000a). The
vascular volume, surface and length were in the same range as
found for human melanomas (Solesvik et al, 1982) or mammary
adenocarcinoma (Hilmas and Gillette, 1974). No correlation
between the vascular parameters and IgG uptake was seen. This
might be because the smallest tumours (< 400 mm3) were not
included in the analysis of the vascular structure. 
Tumour angiogenesis is induced by the interaction between
tumour cells and stromal cells of the host, thereby modulating the
production of various cytokines such as the angiogenic factor
VEGF (Fukumura et al, 1997) or the anti-angiogenic factor TGF-
β 1 (Gohongi et al, 1999). The vascularization might thus depend
on the microenvironment, and whether implantation at an ortho-
topic or ectopic growth site induces angiogenesis, is tumour-
dependent. Both orthotopic (Fidler, 1995) and subcutaneous
(Fukumura et al, 1997; Bernsen et al, 1999) tumours are reported
to be highly vascularized. The higher vascular density of ortho-
topic OHS xenograft should imply a higher uptake of IgG in
orthotopic than in subcutaneous tumours. However, even though
IgG was well distributed throughout the vascular network, trans-
vascular transport and penetration of IgG through the interstitium
might be limited by the high IFP. This might explain why no
difference was seen in IgG uptake between orthotopic and subcu-
taneous tumours larger than 400 mm3. Another explanation might
be that the enhanced IFP and higher vascular density of orthotopic
tumours compared with subcutaneous tumours, will respectively
limit and favour IgG uptake, resulting in no difference in IgG
uptake in the 2 tumour models. 
Clinical implications 
The present data indicate that lowering the IFP and thereby
inducing a transvascular pressure gradient, is an efficient transport
parameters to modulate in order to increase the uptake of thera-
peutic macromolecules. Lowering the IFP might have a more
profound clinical impact than modulating the content of the ECM
constituents. However, the present results can not exclude the
significance of the ECM structure. The assembly and structure of
the ECM might be more important in determining the interstitial
transport than the level of the constituents themselves. 
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